Loading…
EmTech MIT has ended
Throughout the year, Technology Review's editorial staff finds and explains the significance of the new technologies that are disrupting existing industries, creating entirely new markets, and changing society. EmTech MIT brings that editorial content to life. Our annual conference provides you with access to the most innovative people and companies that you should be following, all in a program that will challenge and inspire you.

This year's topics include new approaches to scaling alternative energy sources, the changes digital technologies are bringing to traditional education, the growing significance of personal genomics, the unprecedented impact of big data and social technology on everyday life, and more.

View Expanded Schedule

avatar for Dr. Heidi Rehm

Dr. Heidi Rehm

Knome
Director, Laboratory for Molecular Medicine, Partners Healthcare Center for Personalized Genetic Medicine
Assistant Professor of Pathology, Harvard Medical School

Heidi Rehm, Ph.D. was recruited in 2001 to build the Laboratory for Molecular Medicine at PCPGM and serves as its Laboratory Director. She is a board-certified clinical molecular geneticist and Assistant Professor of Pathology at Harvard Medical School with appointments at BWH, MGH and Children’s Hospital Boston. Her undergraduate degree is from Middlebury College, her graduate degree in Genetics is from Harvard University and her postdoctoral and fellowship training was at HMS. Heidi has served as the Director of the ABMG Clinical Molecular Genetics Training Program at HMS since 2006. In addition to running the LMM and the molecular training program, she also conducts research in hearing loss, Usher syndrome, cardiomyopathy and the use of IT in enabling personalized medicine.